...Ltd. (Royston, U.K.), Evotec OAI AG (FSE:EVT, Hamburg, Germany), Universal Imaging Corp. (Downington, Penn.) and Q3DM Inc....

...the institute to certain biosensor technology for inclusion into Q3DM's cellular imaging products and services. Q3DM Inc....

...Norak and Q3DM will combine their screening technologies to study GPCRs. Norak will contribute its Transfluor...
...technologies to study GPCRs. Norak will contribute its Transfluor fluorescence-based GPCR technology for use on Q3DM's...
...for GPCR drug discovery against an AZN compound library. Norak Biosciences Inc. , Morrisville, N.C. Q3DM Inc....

...Norak ( Research Triangle Park, N.C.) and Q3DM (San Diego, Calif.) will couple their screening technologies...
...their screening technologies to study GPCRs. The deal combines Norak's Transfluor fluorescence-based GPCR technology with Q3DM's...

...II SBIR grant from HHS to develop its second-generation high throughput, high-resolution cellular imaging systems. Q3DM Inc....

...Q3DM and the institute will develop assays using Q3DM’s high throughput microscopy platform to be used...
...high throughput microscopy platform to be used in high throughput cell-based screening for target identification. Q3DM Inc....